Veterinary Medicines

CEVAC VITABRON L vakcina A.U.V.

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain PHY.LMV.42, Live
Download as PDF

Product identification

Medicine name:
CEVAC VITABRON L vakcina A.U.V.
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain PHY.LMV.42, Live
Target species:
  • Chicken (hen)
Route of administration:
  • Intraocular use
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.30
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
  • Newcastle disease virus, strain PHY.LMV.42, Live
    5.50
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Oral lyophilisate
Withdrawal period by route of administration:
  • Intraocular use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Nebulisation use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."